Evotec Stock Price, News & Analysis (OTCMKTS:EVTCY)

$36.11 0.00 (0.00 %)
(As of 02/25/2018 02:58 AM ET)
Previous Close$36.11
Today's Range$36.11 - $36.11
52-Week Range$15.43 - $52.82
Volume68 shs
Average Volume2,033 shs
Market Capitalization$2.65 billion
P/E Ratio80.25
Dividend YieldN/A
Beta0.45

About Evotec (OTCMKTS:EVTCY)

Evotec logoEvotec AG is a drug discovery and development company. The Company operates through two segments. The EVT Execute segment provides standalone drug discover services on a typical fee-for-service basis or integrated drug discovery collaborations on partners' target through a range of commercial structures, including research fees, milestones and/or royalties. The EVT Innovate segment develops drug discovery programs and assets, both internally or through academic collaborations. The Company seeks to partner these into collaborations in return for upfront payments, ongoing research payments. It consists of all partnerships derived from its internally developed assets and platforms and its participations in certain companies. It includes clinical initiations and progress of clinical pipeline within partnerships; expansion of academic BRIDGE network; research and development (R&D) progress with CureX/Target X initiatives, and focuses on induced pluripotent stem cells (iPSC) platform.

Receive EVTCY News and Ratings via Email

Sign-up to receive the latest news and ratings for EVTCY and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry N/A
Sub-IndustryN/A
SectorMedical
SymbolOTCMKTS:EVTCY
CUSIPN/A
Phone49-04-05608-10

Debt

Debt-to-Equity Ratio0.02%
Current Ratio0.69%
Quick Ratio0.64%

Price-To-Earnings

Trailing P/E Ratio80.2462276939488
Forward P/E RatioN/A
P/E GrowthN/A

Sales & Book Value

Annual Sales$179.13 million
Price / Sales14.79
Cash Flow$0.59 per share
Price / Cash61.39
Book Value$3.56 per share
Price / Book10.14

Profitability

Trailing EPS$0.45
Net Income$30.46 million
Net Margins13.34%
Return on Equity11.20%
Return on Assets7.03%

Miscellaneous

Employees1,238
Outstanding Shares73,350,000

Evotec (OTCMKTS:EVTCY) Frequently Asked Questions

What is Evotec's stock symbol?

Evotec trades on the OTCMKTS under the ticker symbol "EVTCY."

When will Evotec make its next earnings announcement?

Evotec is scheduled to release their next quarterly earnings announcement on Tuesday, March, 27th 2018. View Earnings Estimates for Evotec.

Where is Evotec's stock going? Where will Evotec's stock price be in 2018?

4 Wall Street analysts have issued twelve-month target prices for Evotec's stock. Their predictions range from $80.00 to $80.00. On average, they anticipate Evotec's share price to reach $80.00 in the next twelve months. View Analyst Ratings for Evotec.

Who are some of Evotec's key competitors?

Who are Evotec's key executives?

Evotec's management team includes the folowing people:

  • Wolfgang Plischke, Chairman of the Supervisory Board (Age 65)
  • Werner Lanthaler, Chief Executive Officer, Member of the Management Board (Age 49)
  • Bernd Hirsch, Vice Chairman of the Supervisory Board (Age 47)
  • Enno Spillner, Chief Financial Officer, Member of the Management Board (Age 47)
  • Mario Polywka, Chief Operating Officer, Member of the Management Board (Age 54)
  • Cord Dohrmann, Chief Scientific Officer, Member of the Management Board (Age 53)
  • Claus T. Braestrup M.D., Member of the Supervisory Board (Age 72)
  • Paul Linus Herrling Ph.D., Member of the Supervisory Board (Age 64)
  • Iris Loew-Friedrich, Member of the Supervisory Board (Age 57)
  • Michael Shalmi, Member of the Supervisory Board (Age 52)

How do I buy Evotec stock?

Shares of Evotec can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Evotec's stock price today?

One share of Evotec stock can currently be purchased for approximately $36.11.

How big of a company is Evotec?

Evotec has a market capitalization of $2.65 billion and generates $179.13 million in revenue each year. The company earns $30.46 million in net income (profit) each year or $0.45 on an earnings per share basis. Evotec employs 1,238 workers across the globe.

How can I contact Evotec?

Evotec's mailing address is Manfred Eigen Campus Essener Bogen 7, Hamburg 2M, 22419. The company can be reached via phone at 49-04-05608-10 or via email at [email protected]


MarketBeat Community Rating for Evotec (EVTCY)

Community Ranking:  2.7 out of 5 (star star)
Outperform Votes:  97 (Vote Outperform)
Underperform Votes:  84 (Vote Underperform)
Total Votes:  181
MarketBeat's community ratings are surveys of what our community members think about Evotec and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Evotec (OTCMKTS:EVTCY) Analysts' Consensus Rating

  (How are Consensus Ratings Calculated?)
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: HoldHoldHoldHold
Consensus Rating Score: 2.002.002.002.00
Ratings Breakdown: 1 Sell Rating(s)
2 Hold Rating(s)
1 Buy Rating(s)
0 Strong Buy Rating(s)
1 Sell Rating(s)
2 Hold Rating(s)
1 Buy Rating(s)
0 Strong Buy Rating(s)
1 Sell Rating(s)
2 Hold Rating(s)
1 Buy Rating(s)
0 Strong Buy Rating(s)
1 Sell Rating(s)
2 Hold Rating(s)
1 Buy Rating(s)
0 Strong Buy Rating(s)
Consensus Price Target: $80.00$80.00$80.00$80.00
Price Target Upside: 84.08% upside84.08% upside84.08% upside126.89% upside

Evotec (OTCMKTS:EVTCY) Consensus Price Target History

Price Target History for Evotec (OTCMKTS:EVTCY)

Evotec (OTCMKTS:EVTCY) Analyst Ratings History

Show:
DateBrokerageActionRatingPrice TargetDetails
11/8/2017DZ BankReiterated RatingSellView Rating Details
7/25/2017Roth CapitalReiterated RatingBuyView Rating Details
6/6/2017Berenberg BankDowngradeBuy -> HoldView Rating Details
5/3/2017Deutsche BankReiterated RatingNeutralView Rating Details
(Data available from 2/25/2016 forward)

Earnings

Evotec (OTCMKTS:EVTCY) Earnings History and Estimates Chart

Earnings by Quarter for Evotec (OTCMKTS:EVTCY)

Evotec (OTCMKTS EVTCY) Earnings History by Quarter

DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
3/27/2018        
11/8/2017Q3 2017$0.12$0.05$61.30 million$79.24 millionViewN/AView Earnings Details
8/10/2017Q2 2017$0.07$0.04$50.06 million$58.52 millionViewN/AView Earnings Details
5/10/2017Q1 2017$0.10$53.47 millionViewN/AView Earnings Details
3/28/2017Q4 2016$0.32$47.36 millionViewN/AView Earnings Details
11/10/20169/30/2016($0.02)$0.15$42.79 million$50.41 millionViewN/AView Earnings Details
8/10/2016Q2 2016$0.07$39.09 million$42.89 millionViewN/AView Earnings Details
5/10/2016Q1 2016($0.02)($0.02)$38.15 million$41.34 millionViewN/AView Earnings Details
3/22/2016Q4 2015$0.09$45.16 million$43.25 millionViewN/AView Earnings Details
11/10/2015Q3 2015$0.02($0.04)$37.05 million$36.98 millionViewN/AView Earnings Details
8/12/2015Q2 2015$0.02$0.05$38.43 million$36.97 millionViewN/AView Earnings Details
5/12/2015Q1 2015$0.02($0.02)$24.54 million$24.04 millionViewN/AView Earnings Details
3/24/2015Q4 2014$0.02$33.19 millionViewN/AView Earnings Details
11/12/2014Q3 2014$0.04$23.43 millionViewN/AView Earnings Details
8/12/2014Q2 2014($0.01)$30.10 millionViewN/AView Earnings Details
5/14/2014Q1 2014($0.08)$24.19 millionViewN/AView Earnings Details
3/25/2014Q4 2013($0.46)$35.41 millionViewN/AView Earnings Details
11/12/2013Q3 2013$0.03$31.62 millionViewN/AView Earnings Details
8/8/2013Q2 2013($0.04)$26.12 millionViewN/AView Earnings Details
5/14/2013Q1 2013($0.06)$22.14 millionViewN/AView Earnings Details
3/26/2013Q4 2012($0.11)ViewN/AView Earnings Details
11/8/2012Q3 2012$0.12ViewN/AView Earnings Details
8/8/2012Q2 2012$0.07ViewN/AView Earnings Details
5/10/2012Q1 2012($0.05)ViewN/AView Earnings Details
11/10/2011Q3 2011$0.16ViewN/AView Earnings Details
8/11/2011Q2 2011$0.03ViewN/AView Earnings Details
3/24/2011Q4 2010$0.06ViewN/AView Earnings Details
11/11/2010Q3 2010$0.02ViewN/AView Earnings Details
8/12/2010Q2 2010$0.03ViewN/AView Earnings Details
11/12/2009Q3 2009($0.07)ViewN/AView Earnings Details
8/7/2009Q2 2009($0.16)ViewN/AView Earnings Details
5/12/2009Q1 2009($0.50)ViewN/AView Earnings Details
11/14/2008Q3 2008($0.08)ViewN/AView Earnings Details
8/6/2008Q2 2008($0.40)ViewN/AView Earnings Details
(Earnings results data provided by Zacks Investment Research)

Estimates

Evotec (OTCMKTS:EVTCY) Earnings Estimates

No earnings estimates for this company have been tracked by MarketBeat.com

Dividends

Dividend History for Evotec (OTCMKTS:EVTCY)


No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for Evotec (OTCMKTS EVTCY)

No insider trades for this company have been tracked by MarketBeat.com

Headlines

Evotec (OTCMKTS EVTCY) News Headlines

Source:
DateHeadline
Evotec AG :EVTCY-US: Earnings Analysis: Q3, 2017 By the Numbers : January 1, 2018Evotec AG :EVTCY-US: Earnings Analysis: Q3, 2017 By the Numbers : January 1, 2018
finance.yahoo.com - January 1 at 5:31 PM
Evotec (EVTCY) Presents At Jefferies 2017 London Healthcare Conference - SlideshowEvotec (EVTCY) Presents At Jefferies 2017 London Healthcare Conference - Slideshow
seekingalpha.com - November 17 at 5:17 PM
Evotec AG (EVTCY) Set to Announce Earnings on WednesdayEvotec AG (EVTCY) Set to Announce Earnings on Wednesday
www.americanbankingnews.com - November 3 at 11:10 AM
Evotec AG (EVTCY) Scheduled to Post Earnings on ThursdayEvotec AG (EVTCY) Scheduled to Post Earnings on Thursday
www.americanbankingnews.com - August 4 at 3:08 PM

SEC Filings

Evotec (OTCMKTS:EVTCY) SEC Filings

This page is loading this company's SEC Filings. Please wait...

Social Media

Financials

Financials are not available for this stock.

Chart

Evotec (OTCMKTS EVTCY) Stock Chart for Sunday, February, 25, 2018

Loading chart…

This page was last updated on 2/25/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.